Epithelial-Mesenchymal Plasticity in Organotropism Metastasis and Tumor Immune Escape

Xiang Nan, Jiang Wang, Haowen Nikola Liu, Stephen T C Wong, Hong Zhao

Research output: Contribution to journalReview articlepeer-review


Most cancer deaths are due to metastasis, and almost all cancers have their preferential metastatic organs, known as "organotropism metastasis". Epithelial-mesenchymal plasticity has been described as heterogeneous and dynamic cellular differentiation states, supported by emerging experimental evidence from both molecular and morphological levels. Many molecular factors regulating epithelial-mesenchymal plasticity have tissue-specific and non-redundant properties. Reciprocally, cellular epithelial-mesenchymal plasticity contributes to shaping organ-specific pre-metastatic niche (PMN) including distinct local immune landscapes, mainly through secreted bioactive molecular factors. Here, we summarize recent progress on the involvement of tumor epithelial-mesenchymal plasticity in driving organotropic metastasis and regulating the function of different immune cells in organ-specific metastasis.

Original languageEnglish (US)
Journaljournal of clinical medicine
Issue number5
StatePublished - May 25 2019


Dive into the research topics of 'Epithelial-Mesenchymal Plasticity in Organotropism Metastasis and Tumor Immune Escape'. Together they form a unique fingerprint.

Cite this